CPT code 93793 represents the clinical service of reviewing and interpreting a new INR test result for a patient on chronic warfarin therapy, with dose adjustment, patient instruction, and scheduling of further testing as indicated. This code captures a focused anticoagulation management encounter that is important nationally because warfarin remains a widely used oral anticoagulant requiring frequent monitoring to maintain therapeutic ranges and reduce bleeding or thrombotic risk.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will get a concise clinical context for when 93793 is used, expected sites of service (ambulatory clinics, outpatient labs, and telehealth management), and the types of documentation elements tied to this service. The publication also outlines benchmarks and common billing considerations, summarizes relevant payer coverage patterns where available, and highlights recent policy updates affecting anticoagulation management coding and reimbursement. Clinical implications for patient safety and continuity of care are discussed to provide operational context for practices that manage patients on warfarin.

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes is noted where applicable.